滕雯迪檢視原始碼討論檢視歷史
|
滕雯迪，女，北京工商大學講師。
人物簡歷
教育經歷
2009年9月至2013年6月 東北農業大學 獲學士學位
2013年9月至2016年6月 北京化工大學 獲碩士學位
2019年9月至2021年1月 康奈爾大學 聯合培養
2016年9月至2021年7月 中國農業大學 獲博士學位
工作經歷
2021年9月-至今 北京工商大學食品與健康學院 講師
主講課程
分子營養學
研究領域
食源性物質的功能活性及作用機制
功能食品的開發與功能評價
蛋白質翻譯後修飾的功能及其應用
學術成果
論文
1. Wendi Teng, Liyun Zhao, Songtao Yang, Chengying Zhang, Meiyu Liu, Jie Luo, Junhua Jin, Ming Zhang, Chen Bao, Dan Li, Yuan Li and Fazheng Ren*. The hepatic-targeted, resveratrol loaded nanoparticles for relief of high fat diet-induced nonalcoholic fatty liver disease. Journal of Controlled Release, 2019, 307:139-149;
2. Wendi Teng, Yuan Li, Min Du, Xingen Lei, Siyu Xie and Fazheng Ren*. Sulforaphane prevents hepatic insulin resistance by blocking serine palmitoyltransferase 3- mediated ceramide biosynthesis. Nutrients, 2019, 11(5): 1185;
3. Siyu Xie, Yuan Li, Wendi Teng, Min Du, Yixuan Li, Baoguo Sun*. Liensinine inhibits beige adipocytes recovering to white adipocytes through blocking mitophagy flux in vitro and in vivo. Nutrients, 2019, 11(7); 1640;
4. Wendi Teng, Wenjing Yin, Liang Zhao, Changwei Ma, Jiaqiang Huang and Fazheng Ren*. Resveratrol metabolites ameliorate insulin resistance in HepG2 hepatocytes via modulating IRS-1/ AMPK. RSC advances, 2018, 8:36034-36042;
5. Ming Yang, Wendi Teng, Yue Qu, Haiyong Wang and Qipeng Yuan*. Sulforaphene inhibits triple negative breast cancer through activating tumor suppressor Egr1. Breast Cancer Research & Treatment, 2016, 158:277-286;
6. Congcong Zuo, Huijuan Zhang, Shuang Liang, Wendi Teng, Cheng Bao, Dan Li, Yuling Hu, Qimeng Wang, Zekun Li, Yuan Li*. The alleviation of lipid deposition in steatosis hepatocytes by capsaicin-loaded α-lactalbumin nanomicelles via promoted endocytosis and synergetic multiple signaling pathways. Journal of Functional Foods, 2021, 79 (2021), 104396;
7. Ming Yang, Meng Ren, Yue Qu, Wendi Teng, Zhongpeng Wang, Hao Li and Qipeng Yuan*. Sulforaphene inhibits hepatocellular carcinoma through repressing keratin 8 and activating anoikis. RSC Advances, 2016, 6(74):70326-70334.[1]